診断された呼吸疾患を有する患者もしくは診断未確定の呼吸疾患を有する患者におけるオピオイド鎮痛薬の投与に関連する危険性を減少するための方法および組成

Title:

Document Type and Number:

Japanese Patent JP2007505139

Kind Code:

A

Abstract:

The present invention relates to methods for reducing the risk associated with the administration of opioid analgesics in patients diagnosed or undiagnosed with respiratory illness by administering an analgesic composition comprising a sub-analgesic dosage of a [mu]-opioid agonist selected from the group consisting of morphine, fentanyl, sufentanil, alfentanil, oxymorphone and hydromorphone, or a pharmaceutically acceptable salt thereof, and a sub-analgesic dosage of oxycodone which is a K2 -opioid agonist or a pharmaceutically acceptable salt thereof.

More Like This:

WO/2021/222885	TRANSDERMAL DRUG DELIVERY DEVICES HAVING PSILOCYBIN, LYSERGIC ACID DIETHYLAMIDE OR 3,4-METHYLENEDIOXYMETHAMPHETAMINE COATED MICROPROTRUSIONS
WO/2020/058979	METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS
JP2004501955	Liposomal anti-neoplastic agents and their use

Inventors:

Pace, Garry W.
Smith, Marie Tee.

Application Number:

JP2006526349A

Publication Date:

March 08, 2007

Filing Date:

September 10, 2004

Export Citation:

Click for automatic bibliography generation Help

Assignee:

QuX Pharma Pty, Limited

International Classes:

A61K45/06; A61K9/22; A61K31/135; A61K31/445; A61K31/4468; A61K31/485; A61P11/00; A61P11/06; A61P25/04; A61P25/20; A61P35/00; A61P43/00

Domestic Patent References:

JP2000511158A

2000-08-29

Attorney, Agent or Firm:

Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita

Previous Patent: 末端に連結された二環糖部分を有する、ギャップ化オリゴマー化合物

Next Patent: インスリン様成長因子−１（ＩＧＦ−１）欠損症の治療法